Associate Professor of Cell and Gene Therapy Bioprocess Engineering, UCL
Qasim Rafiq is an Associate Professor of Cell and Gene Therapy Bioprocess Engineering at University College London and Programme Director of a new MSc programme focused on the Manufacture and Commercialisation of Stem Cell and Gene Therapies. He is a multidisciplinary engineer working at the life science, engineering and commercial interfaces with a research focus on the bioprocessing, automation and biomanufacture of cell and gene-based therapies. He has a specific interest in addressing the large-scale manufacturing challenges and enhancing process and product understanding to enable the successful translation of therapeutics from the laboratory to the clinic.
Qasim is both a Chartered Engineer (CEng) and Chartered Scientist (CSci) and sits on multiple scientific and engineering committees including the UK Society for Cell Culture Biotechnology (ESACT-UK) where he is the Scientific Programme Lead, the IChemE Biochemical Engineering Subject Interest Group, British Standards Institute Biotechnology Committee and the BioIndustry Association's Cell and Gene Therapy Advisory Committee.
He has won awards for his research and public engagement activities and in 2020 was recognised as one of the top 20 influential and inspirational individuals in Advanced Medicine by The Medicine Maker listed amongst Nobel Laureates, multi-national CEOs and leading scientists.
May 14, 2020 10:12 am UTC| Health
There are 102 candidate vaccines being explored as a means of ending the COVID-19 pandemic, as of April 30. Eight of these have already made it to clinical trials in humans, and another 94 are in the pre-clinical...